Page last updated: 2024-08-17

folic acid and Aortic Valve Stenosis

folic acid has been researched along with Aortic Valve Stenosis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bleie, Ø; Ebbing, M; Nilsen, DW; Nordrehaug, JE; Nygård, O; Pedersen, EK; Refsum, H; Ueland, PM; Vollset, SE	1
Lundberg, GD	1
Andelfinger, GU; Bigras, JL; Christensen, KE; Dubé, MP; Michaud, JL; Richter, A; Rohlicek, CV; Rozen, R; Zada, YF	1
MEERSON, FZ	1
Funck, RC; Heymanns, J; Maisch, B; Mandic, R; Wagner, AC	1

Trials

1 trial(s) available for folic acid and Aortic Valve Stenosis

Article	Year
Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA, 2008, Aug-20, Volume: 300, Issue:7 Topics: Aged; Aortic Valve Stenosis; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk; Vitamin B 12; Vitamin B 6; Vitamin B Complex	2008

Article

Year

Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.

JAMA, 2008, Aug-20, Volume: 300, Issue:7

Topics: Aged; Aortic Valve Stenosis; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Risk; Vitamin B 12; Vitamin B 6; Vitamin B Complex

2008

Other Studies

4 other study(ies) available for folic acid and Aortic Valve Stenosis

Article	Year
Homocysteine-lowering B vitamins do not lower mortality or cardiovascular events. Medscape journal of medicine, 2008, Volume: 10, Issue:12 Topics: Aged; Aortic Valve Stenosis; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk; Survival Analysis; Survival Rate; Vitamin B 12; Vitamin B 6; Vitamin B Complex	2008
Risk of congenital heart defects is influenced by genetic variation in folate metabolism. Cardiology in the young, 2013, Volume: 23, Issue:1 Topics: Aortic Valve Stenosis; Case-Control Studies; Female; Ferredoxin-NADP Reductase; Folic Acid; Gene Frequency; Genetic Predisposition to Disease; Genotype; Heart Defects, Congenital; Heart Septal Defects, Ventricular; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Odds Ratio; Phenotype; Polymorphism, Single Nucleotide; Reduced Folate Carrier Protein	2013
A MECHANISM OF HYPERTROPHY AND WEAR OF THE MYOCARDIUM. The American journal of cardiology, 1965, Volume: 15 Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Aortic Valve Stenosis; Cardiomegaly; Cardiomyopathies; DNA; Dogs; Folic Acid; Humans; Hypertrophy; Methionine; Muscle Proteins; Myocardium; Nucleic Acids; Nucleosides; Orotic Acid; Pharmacology; Rabbits; Rats; Research; Strophanthins; Vitamin B 12	1965
Anemia with LDH-elevation in a patient with aortic valve replacement. Herz, 1994, Volume: 19, Issue:3 Topics: Anemia, Hemolytic; Anemia, Pernicious; Aortic Valve Stenosis; Biopsy; Blood Flow Velocity; Bone Marrow; Diagnosis, Differential; Echocardiography, Doppler; Echocardiography, Transesophageal; Folic Acid; Gastric Mucosa; Heart Valve Prosthesis; Hemodynamics; Hemoglobinometry; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Postoperative Complications; Prosthesis Failure; Vitamin B 12	1994